Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Cars.com ( CAR) (upgraded to Overweight from Neutral): "There are signs of improvement in product development and adoption, ...

Palantir (NASDAQ: PLTR) stock saw a massive rally across the first half of 2025's trading. The tech company's share price ...

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The Pittsburgh bank and financial-services company reported net income of ...

Renault cut its guidance for this year's operating margins to 6.5% from around 7% earlier. Additionally, the company also cut ...

AAM Stockholders Approve Proposed Combination DETROIT, July 15, 2025 /PRNewswire/ -- American Axle & Manufacturing Holdings, Inc. ("AAM"), (NYSE: ...

Stellantis (NYSE:STLA) announced on Wednesday that it is ending its development efforts for hydrogen fuel cell technology, shifting away from a strategy once seen as part of its alternative energy ...

Stellantis said it would discontinue its hydrogen fuel-cell technology development program because it doesn't expect the adoption of hydrogen-powered light commercial vehicles before the end of the ...

Darn! Missed by a whisker. My Perfect 10 Portfolio returned 14.6% in the past year, a hair behind the Standard & Poor’s 500 ...

Stellantis hasn’t announced a launch date for the 2026 Hornet, and plenty of 2024 and 2025 models remain in stock ...

The outlook for European corporate health has deteriorated, the latest earnings forecasts showed on Tuesday, as U.S.

Rivian is under intense investor scrutiny in 2025 as revenue risks, production targets, and strategic shifts raise critical ...